Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) released a profit for its full year that Increased, from last year
The company's bottom line totaled RMB730.073 million, or RMB0.82 per share. This compares with RMB606.096 million, or RMB0.68 per share, last year.
The company's revenue for the period rose 6.7% to RMB5.508 billion from RMB5.160 billion last year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB730.073 Mln. vs. RMB606.096 Mln. last year.-EPS: RMB0.82 vs. RMB0.68 last year.-Revenue: RMB5.508 Bln vs. RMB5.160 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.